Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development.

Citation data:

Frontiers of medicine, ISSN: 2095-0225, Vol: 5, Issue: 2, Page: 171-7

Publication Year:
2011
Usage 17
Abstract Views 17
Captures 11
Readers 10
Exports-Saves 1
Social Media 5
Shares, Likes & Comments 5
Citations 40
Citation Indexes 39
Clinical Citations 1
Repository URL:
https://repository.hkbu.edu.hk/hkbu_staff_publication/1579
PMID:
21695622
DOI:
10.1007/s11684-011-0132-z
Author(s):
Bian, Zhaoxiang; Liu, Baoyan; Moher, David; Wu, Taixiang; Li, Youping; Shang, Hongcai; Cheng, Chungwah
Publisher(s):
Springer Nature; Springer Verlag
Tags:
Medicine; CONSORT for TCM; Future development; Reporting standards
review description
The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name "CONSORT," which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.